Teladoc Health, Inc. (TDOC) · Oct 28, 2026 · Earnings
Beat — Revenue $605.1M vs ~$588.5M consensus; adjusted EBITDA $79.4M vs $62M-$74M guide
Teladoc’s Q3 earnings beat revenue and EBITDA expectations, while BetterHelp’s insurance transition deepened the decline in cash-pay demand.
Teladoc is in an execution phase: strengthening its employer-and-health-plan Integrated Care business, rolling out Teladoc One, and shifting BetterHelp from direct cash pay toward insurance-covered therapy. That transition is intended to broaden access, but it is also pressuring the legacy consumer model.
The quarter beat the market’s operating expectations. Revenue reached $605.1 million versus a published consensus of roughly $588.5 million, while diluted loss per share was $0.15 versus an expected loss of about $0.22. Adjusted EBITDA was $79.4 million, above the company’s prior $62 million-$74 million range. Revenue was near the top of management’s range, and profitability was clearly above it.
| Metric | Q3 2026 | Comparison / expectation |
|---|---|---|
| Revenue | $605.1M | ~$588.5M consensus; $626.4M year ago |
| Net loss per share | $(0.15) | $(0.28) year ago; ~$$(0.22) consensus |
| Adjusted EBITDA | $79.4M | $62M-$74M prior guide; $69.9M year ago |
| Integrated Care revenue | $398.5M | +2% year over year |
| Integrated Care adjusted EBITDA | $74.9M | +13% year over year; 18.8% margin |
| BetterHelp revenue | $206.6M | -13% year over year |
| BetterHelp adjusted EBITDA | $4.5M | +17% year over year; 2.2% margin |
| Nine-month free cash flow | $85.4M | $113.5M year ago |
| Full-year revenue outlook | $2.395B-$2.441B | Prior range: $2.362B-$2.447B |
| Full-year adjusted EBITDA outlook | $277M-$303M | Prior range: $271M-$303M |
Integrated Care is carrying the business. Segment revenue grew 2%, adjusted EBITDA rose 13%, and the margin expanded to 18.8%, suggesting the core employer, health-plan, and enterprise-care operation is executing better even while consolidated revenue remains down.
BetterHelp’s transition is working directionally but not yet financially. Insurance-covered revenue jumped to $32.1 million from $3.7 million, but Consumer and Other revenue fell 25% to $174.5 million, leaving total BetterHelp revenue down 13%. The filing confirms that insurance adoption is replacing cash-pay revenue faster than the new channel can offset it.
Management modestly improved the full-year framework, but mainly on profitability rather than growth. The revenue range moved higher at the low end and lower at the high end, while the adjusted EBITDA range rose from $271 million-$303 million to $277 million-$303 million. Free-cash-flow guidance also narrowed to $135 million-$165 million from $130 million-$170 million. That is a better execution signal, not a return to broad-based revenue growth.
Cash generation remains a blemish beneath the EBITDA beat. Nine-month operating cash flow fell to $180.6 million from $206.6 million, and free cash flow dropped to $85.4 million from $113.5 million, even though third-quarter cash flow improved. The company ended with $849.9 million of cash, but nearly $1.0 billion of convertible notes is classified as current, making cash conversion and balance-sheet management relevant to the next phase.
Bottom line: This is a genuine earnings beat led by Integrated Care and better cost control, with guidance modestly tightened upward. The central turnaround issue is unresolved: BetterHelp is gaining insurance revenue, but the cash-pay decline still overwhelms that progress at the consolidated level.
Q4 report and January Teladoc One launch
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!